PCA3 and breast carcinoma: Contrary to the PCA3 promoter, the PSA chimeric promoter, PSEBC, was highly androgen responsive in AR-expressing PCa cell lines and it was also active in AR-expressing breast cancer cells such as CAMA-1 and ZR-75-1 (Figure 1B).